Clinical Features of Severe or Fatal Mycoplasma pneumoniae Pneumonia
Open Access
- 1 June 2016
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 7, 800
Abstract
Mycoplasma pneumoniae is one of the most common causes of community-acquired pneumonia in children and young adults. The incidence of fulminant M. pneumoniae pneumonia (MPP) is relatively rare despite the high prevalence of M. pneumoniae infection. This literature review highlights the clinical features of fulminant MPP by examining the most recent data in epidemiology, clinical presentation, pathogenesis, and treatment. Fulminant MPP accounts for 0.5-2% of all MPP cases and primarily affects young adults with no underlying disease. Key clinical findings include a cough, fever, and dyspnea along with diffuse abnormal findings in radiological examinations. Levels of inflammatory markers such as white blood cells (WBC) and C-reactive protein (CRP) are elevated, as well as levels of lactate dehydrogenase (LDH), IL-18, AST, and ALT. The exact pathogenesis of fulminant MPP remains unclear, but theories include a delayed hypersensitivity reaction to Mycoplasma pneumoniae and the contribution of delayed antibiotic administration to disease progression. Treatment options involve pairing the appropriate anti-mycoplasmal agent with a corticosteroid that will downregulate the hypersensitivity response, and mortality rates are quite low in this treatment group. Further research is necessary to determine the exact pathogenesis of severe and fulminant types of MPP.Keywords
This publication has 15 references indexed in Scilit:
- Lactate Dehydrogenase as a Biomarker for Prediction of Refractory Mycoplasma pneumoniae Pneumonia in ChildrenRespiratory Care, 2015
- Setting a standard for the initiation of steroid therapy in refractory or severe Mycoplasma pneumoniae pneumonia in adolescents and adultsJournal of Infection and Chemotherapy, 2015
- Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia: A review of the Japanese literatureJournal of Infection and Chemotherapy, 2014
- Fulminant and Fatal Multiple Organ Failure in a 12-Year-Old Boy WithMycoplasma pneumoniaeInfectionAllergy, Asthma & Immunology Research, 2012
- Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unitJournal of Medical Microbiology, 2007
- The JRS Guidelines for the Management of Community-acquired Pneumonia in Adults:An Update and New RecommendationsInternal Medicine, 2006
- Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient studyJournal of Medical Microbiology, 2005
- A 3-year prospective study of a urinary antigen-detection test for Streptococcus pneumoniae in community-acquired pneumonia: utility and clinical impact on the reported etiologyJournal of Infection and Chemotherapy, 2004
- Fulminant Mycoplasma pneumoniae pneumonia.1995
- Intranasal inoculation ofMycoplasma pulmonisin mice with severe combined immunodeficiency (SCID) causes a wasting disease with grave arthritisClinical and Experimental Immunology, 1994